T1	Participants 457 505	97 patients with recurrent condylomata acuminata
T2	Participants 521 656	9 patients were treated with cryotherapy plus subcutaneously administered interferon alpha-2a, and 48 received cryotherapy plus placebo
T3	Participants 668 721	36 and 37 patients, respectively, completed the study
T4	Participants 1137 1218	only 31% of interferon and 27% of placebo recipients remained free of recurrences
T5	Participants 1243 1460	Interferon alpha-2a administered subcutaneously offers no benefit as a chemotherapeutic adjuvant to cryotherapy when used alone in the therapy of genital warts in this population of patients with recurrent condylomata
